SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nancy Monroy-Jaramillo, Jorge Luis Guerrero-Camacho, Mayela Rodríguez-Violante, Marie-Catherine Boll-Woehrlen, Petra Yescas-Gómez, María Elisa Alonso-Vilatela, Marisol López-López, Genetic mutations in early-onset Parkinson's disease Mexican patients: Molecular testing implications, American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2014, 165, 3
  2. 2
    Ismail Ismailoglu, Qiuying Chen, Melissa Popowski, Lili Yang, Steven S. Gross, Ali H. Brivanlou, Huntingtin protein is essential for mitochondrial metabolism, bioenergetics and structure in murine embryonic stem cells, Developmental Biology, 2014, 391, 2, 230

    CrossRef

  3. 3
    Zhi Dong Zhou, Fathima Shaffra Refai, Shao Ping Xie, Shin Hui Ng, Christine Hui Shan Chan, Patrick Ghim Hoe Ho, Xiao Dong Zhang, Tit Meng Lim, Eng King Tan, Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons, Free Radical Biology and Medicine, 2014, 68, 220

    CrossRef

  4. 4
    Lee J. Martin, Samantha Semenkow, Allison Hanaford, Margaret Wong, The mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice, Neurobiology of Aging, 2014, 35, 5, 1132

    CrossRef

  5. 5
    Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha G. Kanthasamy, Biomarkers in Toxicology, 2014,

    CrossRef

  6. 6
    Gavin I. Ellis, Lianteng Zhi, Ravi Akundi, Hansruedi Büeler, Francesc Marti, Mitochondrial and cytosolic roles of PINK1 shape induced regulatory T-cell development and function, European Journal of Immunology, 2013, 43, 12
  7. 7
    Stephen Mullin, Anthony Schapira, α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease, Molecular Neurobiology, 2013, 47, 2, 587

    CrossRef

  8. 8
    D. Santos, S.M. Cardoso, Mitochondrial dynamics and neuronal fate in Parkinson's disease, Mitochondrion, 2012, 12, 4, 428

    CrossRef

  9. 9
    O. Cooper, H. Seo, S. Andrabi, C. Guardia-Laguarta, J. Graziotto, M. Sundberg, J. R. McLean, L. Carrillo-Reid, Z. Xie, T. Osborn, G. Hargus, M. Deleidi, T. Lawson, H. Bogetofte, E. Perez-Torres, L. Clark, C. Moskowitz, J. Mazzulli, L. Chen, L. Volpicelli-Daley, N. Romero, H. Jiang, R. J. Uitti, Z. Huang, G. Opala, L. A. Scarffe, V. L. Dawson, C. Klein, J. Feng, O. A. Ross, J. Q. Trojanowski, V. M.- Y. Lee, K. Marder, D. J. Surmeier, Z. K. Wszolek, S. Przedborski, D. Krainc, T. M. Dawson, O. Isacson, Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease, Science Translational Medicine, 2012, 4, 141, 141ra90

    CrossRef

  10. 10
    J. Robert Chang, Mohammad Ghafouri, Ruma Mukerjee, Asen Bagashev, Tinatin Chabrashvili, Bassel E. Sawaya, Role of p53 in Neurodegenerative Diseases, Neurodegenerative Diseases, 2012, 9, 2, 68

    CrossRef

  11. 11
    Laura L. Kilarski, Justin P. Pearson, Victoria Newsway, Elisa Majounie, M. Duleeka W. Knipe, Anjum Misbahuddin, Patrick F. Chinnery, David J. Burn, Carl E. Clarke, Marie-Helene Marion, Alistair J. Lewthwaite, David J. Nicholl, Nicholas W. Wood, Karen E. Morrison, Caroline H. Williams-Gray, Jonathan R. Evans, Stephen J. Sawcer, Roger A. Barker, Mirdhu M. Wickremaratchi, Yoav Ben-Shlomo, Nigel M. Williams, Huw R. Morris, Systematic Review and UK-Based Study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease, Movement Disorders, 2012, 27, 12
  12. 12
    Alexander I. May, Rodney J. Devenish, Mark Prescott, The Many Faces of Mitochondrial Autophagy: Making Sense of Contrasting Observations in Recent Research, International Journal of Cell Biology, 2012, 2012, 1

    CrossRef

  13. 13
    Anthony Schapira, Mitochondrial Signaling in Health and Disease, 2012,

    CrossRef

  14. 14
    Lee J. Martin, Molecular Biology of Neurodegenerative Diseases, 2012,

    CrossRef

  15. 15
    Hilla Weidberg, Elena Shvets, Zvulun Elazar, Biogenesis and Cargo Selectivity of Autophagosomes, Annual Review of Biochemistry, 2011, 80, 1, 125

    CrossRef

  16. 16
    Madeleine Diedrich, Tohru Kitada, Grit Nebrich, Andrea Koppelstaetter, Jie Shen, Claus Zabel, Joachim Klose, Lei Mao, Brain region specific mitophagy capacity could contribute to selective neuronal vulnerability in Parkinson's disease, Proteome Science, 2011, 9, 1, 59

    CrossRef

  17. 17
    Marta d’Amora, Cristiano Angelini, Manuela Marcoli, Chiara Cervetto, Tohru Kitada, Mauro Vallarino, Expression of PINK1 in the brain, eye and ear of mouse during embryonic development, Journal of Chemical Neuroanatomy, 2011, 41, 2, 73

    CrossRef

  18. 18
    Sumihiro Kawajiri, Shinji Saiki, Shigeto Sato, Nobutaka Hattori, Genetic mutations and functions of PINK1, Trends in Pharmacological Sciences, 2011, 32, 10, 573

    CrossRef

  19. 19
    Shigeto Sato, Nobutaka Hattori, Genetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  20. 20
    Thomas Gasser, John Hardy, Yoshikuni Mizuno, Milestones in PD genetics, Movement Disorders, 2011, 26, 6
  21. 21
    Anthony H. V. Schapira, Matthew Gegg, Mitochondrial Contribution to Parkinson's Disease Pathogenesis, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  22. 22
    O. A. Buneeva, A. E. Medvedev, Mitochondrial dysfunction in Parkinson’s disease, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2011, 5, 4, 313

    CrossRef

  23. You have free access to this content23
    Anthony H. V. Schapira, Mitochondrial Pathology in Parkinson's Disease, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 6
  24. 24
    Hung-Li Wang, An-Hsun Chou, Ai-Shun Wu, Si-Ying Chen, Yi-Hsin Weng, Yu-Cheng Kao, Tu-Hsueh Yeh, Po-Ju Chu, Chin-Song Lu, PARK6 PINK1 mutants are defective in maintaining mitochondrial membrane potential and inhibiting ROS formation of substantia nigra dopaminergic neurons, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011, 1812, 6, 674

    CrossRef

  25. 25
    W. Yu, Y. Sun, S. Guo, B. Lu, The PINK1/Parkin pathway regulates mitochondrial dynamics and function in mammalian hippocampal and dopaminergic neurons, Human Molecular Genetics, 2011, 20, 16, 3227

    CrossRef

  26. 26
    Brandon K. Harvey, Christopher T. Richie, Barry J. Hoffer, Mikko Airavaara, Transgenic animal models of neurodegeneration based on human genetic studies, Journal of Neural Transmission, 2011, 118, 1, 27

    CrossRef

  27. 27
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  28. 28
    S. Lesage, A. Brice, Bases moléculaires de la maladie de Parkinson, EMC - Neurologie, 2010, 7, 1, 1

    CrossRef

  29. 29
    S. Lesage, A. Brice, Basi molecolari del morbo di Parkinson, EMC - Neurologia, 2010, 10, 2, 1

    CrossRef

  30. 30
    Karen Nuytemans, Jessie Theuns, Marc Cruts, Christine Van Broeckhoven, Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update, Human Mutation, 2010, 31, 7
  31. 31
    Hideaki Matsui, Yoshihito Taniguchi, Haruhisa Inoue, Yoshito Kobayashi, Yoshiyuki Sakaki, Atsushi Toyoda, Kengo Uemura, Daisuke Kobayashi, Shunichi Takeda, Ryosuke Takahashi, Loss of PINK1 in medaka fish (Oryzias latipes) causes late-onset decrease in spontaneous movement, Neuroscience Research, 2010, 66, 2, 151

    CrossRef

  32. 32
    Hansruedi Büeler, Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease, Apoptosis, 2010, 15, 11, 1336

    CrossRef

  33. 33
    Ji-feng Guo, Xue-wei Zhang, Li-luo Nie, Hai-nan Zhang, Bin Liao, Jing Li, Lei Wang, Xin-xiang Yan, Bei-sha Tang, Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism, Journal of Neurology, 2010, 257, 7, 1170

    CrossRef

  34. 34
    Sumihiro Kawajiri, Shinji Saiki, Shigeto Sato, Fumiaki Sato, Taku Hatano, Hiroto Eguchi, Nobutaka Hattori, PINK1 is recruited to mitochondria with parkin and associates with LC3 in mitophagy, FEBS Letters, 2010, 584, 6, 1073

    CrossRef

  35. You have free access to this content35
    Yasuhiro Yamamura, The long journey to the discovery of PARK2, Neuropathology, 2010, 30, 5
  36. 36
    Charleen T. Chu, Tickled PINK1: Mitochondrial homeostasis and autophagy in recessive Parkinsonism, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010, 1802, 1, 20

    CrossRef

  37. 37
    Thomas Gasser, Recent Advances in Parkinson’s Disease: Basic Research, 2010,

    CrossRef

  38. 38
    Enza Maria valente, Alessandro Ferraris, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  39. 39
    Ian Martin, Valina L. Dawson, Ted M. Dawson, Recent Advances in Parkinson’s Disease: Basic Research, 2010,

    CrossRef

  40. 40
    Anthony H.V. Schapira, Etiology and Pathogenesis of Parkinson Disease, Neurologic Clinics, 2009, 27, 3, 583

    CrossRef

  41. 41
    Caroline Pirkevi, Suzanne Lesage, Alexis Brice, A. Nazli Başak, From Genes to Proteins in Mendelian Parkinson's Disease: An Overview, The Anatomical Record, 2009, 292, 12
  42. 42
    Maria G. Macedo, Dagmar Verbaan, Yue Fang, Stephanie M. van Rooden, Martine Visser, Burcu Anar, Antonella Uras, Justus L. Groen, Patrizia Rizzu, Jacobus J. van Hilten, Peter Heutink, Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease, Movement Disorders, 2009, 24, 2
  43. 43
    Cristofol Vives-Bauza, Rosa L.A. de Vries, Maja Aleksandra Tocilescu, Serge Przedborski, Is there a pathogenic role for mitochondria in Parkinson's disease?, Parkinsonism & Related Disorders, 2009, 15, S241

    CrossRef

  44. 44
    Thomas Gasser, Molecular pathogenesis of Parkinson disease: insights from genetic studies, Expert Reviews in Molecular Medicine, 2009, 11,

    CrossRef

  45. 45
    Roberta Marongiu, Brian Spencer, Leslie Crews, Anthony Adame, Christina Patrick, Margarita Trejo, Bruno Dallapiccola, Enza Maria Valente, Eliezer Masliah, Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson’s disease by disturbing calcium flux, Journal of Neurochemistry, 2009, 108, 6
  46. 46
    Hiroyuki Tomiyama, Yuanzhe Li, Hiroyo Yoshino, Yoshikuni Mizuno, Shin-ichiro Kubo, Tatsushi Toda, Nobutaka Hattori, Mutation analysis for DJ-1 in sporadic and familial parkinsonism: Screening strategy in parkinsonism, Neuroscience Letters, 2009, 455, 3, 159

    CrossRef

  47. 47
    Anthony H.V. Schapira, Neurobiology and treatment of Parkinson's disease, Trends in Pharmacological Sciences, 2009, 30, 1, 41

    CrossRef

  48. 48
    Taku Hatano, Shin-ichiro Kubo, Shigeto Sato, Nobutaka Hattori, Pathogenesis of familial Parkinson’s disease: new insights based on monogenic forms of Parkinson’s disease, Journal of Neurochemistry, 2009, 111, 5
  49. 49
    Clecio Godeiro-Junior, Patricia M. de Carvalho-Aguiar, Andre C. Felício, Orlando G.P. Barsottini, Sonia M.A. Silva, Vanderci Borges, Luiz Augusto F. Andrade, Henrique Ballalai Ferraz, PINK1 mutations in a Brazilian cohort of early-onset Parkinson's disease patients, Movement Disorders, 2009, 24, 11
  50. 50
    George D. Mellick, Gerhard A. Siebert, Manabu Funayama, Daniel D. Buchanan, Yuanzhe Li, Yoko Imamichi, Hiroyo Yoshino, Peter A. Silburn, Nobutaka Hattori, Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia, Parkinsonism & Related Disorders, 2009, 15, 2, 105

    CrossRef

  51. 51
    Hiroshi Yamashita, Tatsuo Kohriyama, Tomohiko Ohshita, Tetsuya Takahashi, Kazuo Hashikawa, Nobutaka Hattori, Hidenao Fukuyama, Masayasu Matsumoto, A case of a 30-year history of PARK6 -Findings from functional imaging of the brai-, Rinsho Shinkeigaku, 2008, 48, 9, 662

    CrossRef

  52. 52
    Amy K. Reeve, Kim J. Krishnan, Doug M. Turnbull, Age related mitochondrial degenerative disorders in humans, Biotechnology Journal, 2008, 3, 6
  53. 53
    Ryan D. Mills, Chou Hung Sim, Su San Mok, Terrence D. Mulhern, Janetta G. Culvenor, Heung-Chin Cheng, Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1), Journal of Neurochemistry, 2008, 105, 1
  54. 54
    J. Prestel, K. Gempel, T. K. Hauser, K. Schweitzer, H. Prokisch, U. Ahting, D. Freudenstein, E. Bueltmann, T. Naegele, D. Berg, T. Klopstock, T. Gasser, Clinical and molecular characterisation of a Parkinson family with a novel PINK1 mutation, Journal of Neurology, 2008, 255, 5, 643

    CrossRef

  55. 55
    A. Torkamani, N. Kannan, S. S. Taylor, N. J. Schork, Congenital disease SNPs target lineage specific structural elements in protein kinases, Proceedings of the National Academy of Sciences, 2008, 105, 26, 9011

    CrossRef

  56. 56
    Manabu Funayama, Yuanzhe Li, Tak-Hong Tsoi, Ching-Wan Lam, Takekazu Ohi, Shogo Yazawa, Eiichiro Uyama, Ruth Djaldetti, Eldad Melamed, Hiroyo Yoshino, Yoko Imamichi, Hiroshi Takashima, Kenya Nishioka, Kenichi Sato, Hiroyuki Tomiyama, Shin-Ichiro Kubo, Yoshikuni Mizuno, Nobutaka Hattori, Familial Parkinsonism with digenic parkin and PINK1 mutations, Movement Disorders, 2008, 23, 10
  57. 57
    Saskia Biskup, Manfred Gerlach, Andreas Kupsch, Heinz Reichmann, Peter Riederer, Peter Vieregge, Ullrich Wüllner, Thomas Gasser, Genes associated with Parkinson syndrome, Journal of Neurology, 2008, 255, S5, 8

    CrossRef

  58. 58
    S H Y Loh, L Francescut, P Lingor, M Bähr, P Nicotera, Identification of new kinase clusters required for neurite outgrowth and retraction by a loss-of-function RNA interference screen, Cell Death and Differentiation, 2008, 15, 2, 283

    CrossRef

  59. 59
    Giovanni Savettieri, Grazia Annesi, Donatella Civitelli, Innocenza Claudia Cirò Candiano, Giuseppe Salemi, Paolo Ragonese, Ferdinanda Annesi, Patrizia Tarantino, Valeria Terruso, Marco D'Amelio, Aldo Quattrone, Identification of the novel D297fsX318 PINK1 mutation and phenotype variation in a family with early-onset Parkinson's disease, Parkinsonism & Related Disorders, 2008, 14, 6, 509

    CrossRef

  60. 60
    Yasuhiro Moriwaki, Yeon-Jeong Kim, Yukari Ido, Hidemi Misawa, Koichiro Kawashima, Shogo Endo, Ryosuke Takahashi, L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner, Neuroscience Research, 2008, 61, 1, 43

    CrossRef

  61. 61
    Kathrin Reetz, Rebekka Lencer, Susanne Steinlechner, Christian Gaser, Johann Hagenah, Christian Büchel, Dirk Petersen, Norman Kock, Ana Djarmati, Hartwig R. Siebner, Christine Klein, Ferdinand Binkofski, Limbic and Frontal Cortical Degeneration Is Associated with Psychiatric Symptoms in PINK1 Mutation Carriers, Biological Psychiatry, 2008, 64, 3, 241

    CrossRef

  62. 62
    Anthony HV Schapira, Mitochondria in the aetiology and pathogenesis of Parkinson's disease, The Lancet Neurology, 2008, 7, 1, 97

    CrossRef

  63. 63
    M. I. Shadrina, P. A. Slominsky, Mitochondrial dysfunction and oxidative damage in the molecular pathology of Parkinson’s disease, Molecular Biology, 2008, 42, 5, 720

    CrossRef

  64. 64
    Ji-Feng Guo, Bin Xiao, Bing Liao, Xue-Wei Zhang, Li-Luo Nie, Yu-Hu Zhang, Lu Shen, Hong Jiang, Kun Xia, Qian Pan, Xin-Xiang Yan, Bei-Sha Tang, Mutation analysis of Parkin, PINK1, DJ-1 and ATP13A2 genes in Chinese patients with autosomal recessive early-onset Parkinsonism, Movement Disorders, 2008, 23, 14
  65. 65
    Brendan Looyenga, Alyse DeHaan, Jeffrey MacKeigan, Pink1, AfCS-Nature Molecule Pages, 2008,

    CrossRef

  66. 66
    Y. Mizuno, N. Hattori, S.-i. Kubo, S. Sato, K. Nishioka, T. Hatano, H. Tomiyama, M. Funayama, Y. Machida, H. Mochizuki, Progress in the pathogenesis and genetics of Parkinson's disease, Philosophical Transactions of the Royal Society B: Biological Sciences, 2008, 363, 1500, 2215

    CrossRef

  67. 67
    Helene Plun-Favreau, Sonia Gandhi, Alison Wood-Kaczmar, Emma Deas, Zhi Yao, Nicholas W. Wood, What Have PINK1 and HtrA2 Genes Told Us about the Role of Mitochondria in Parkinson's Disease?, Annals of the New York Academy of Sciences, 2008, 1147, 1
  68. 68
    Christine Klein, Katja Lohmann-Hedrich, Ekaterina Rogaeva, Michael G Schlossmacher, Anthony E Lang, Deciphering the role of heterozygous mutations in genes associated with parkinsonism, The Lancet Neurology, 2007, 6, 7, 652

    CrossRef

  69. 69
    Nathan Pankratz, Tatiana Foroud, Genetics of Parkinson disease, Genetics in Medicine, 2007, 9, 12, 801

    CrossRef

  70. 70
    Michael R Douglas, Alistair J Lewthwaite, David J Nicholl, Genetics of Parkinson’s disease and parkinsonism, Expert Review of Neurotherapeutics, 2007, 7, 6, 657

    CrossRef

  71. 71
    T. Kitada, A. Pisani, D. R. Porter, H. Yamaguchi, A. Tscherter, G. Martella, P. Bonsi, C. Zhang, E. N. Pothos, J. Shen, Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice, Proceedings of the National Academy of Sciences, 2007, 104, 27, 11441

    CrossRef

  72. 72
    S. Lesage, A. Dürr, A. Brice, LRRK2: a link between familial and sporadic Parkinson’s disease?, Pathologie Biologie, 2007, 55, 2, 107

    CrossRef

  73. 73
    A H V Schapira, Mitochondrial dysfunction in Parkinson's disease, Cell Death and Differentiation, 2007, 14, 7, 1261

    CrossRef

  74. 74
    Hans-Hermann Hoepken, Suzana Gispert, Blas Morales, Oliver Wingerter, Domenico Del Turco, Alexander Mülsch, Robert L. Nussbaum, Klaus Müller, Stefan Dröse, Ulrich Brandt, Thomas Deller, Brunhilde Wirth, Alexei P. Kudin, Wolfram S. Kunz, Georg Auburger, Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6, Neurobiology of Disease, 2007, 25, 2, 401

    CrossRef

  75. 75
    J. Doostzadeh, J.W. Tetrud, M. Allen-Auerbach, J.W. Langston, B. Schüle, Novel features in a patient homozygous for the L347P mutation in the PINK1 gene, Parkinsonism & Related Disorders, 2007, 13, 6, 359

    CrossRef

  76. 76
    Eng-King Tan, Lisa M. Skipper, Pathogenic mutations in Parkinson disease, Human Mutation, 2007, 28, 7
  77. 77
    Hung-Li Wang, An-Hsun Chou, Tu-Hsueh Yeh, Allen H. Li, Ying-Ling Chen, Yu-Li Kuo, Shu-Ru Tsai, Szu-Tzu Yu, PINK1 mutants associated with recessive Parkinson’s disease are defective in inhibiting mitochondrial release of cytochrome c, Neurobiology of Disease, 2007, 28, 2, 216

    CrossRef

  78. 78
    Yi-Hsin Weng, Yah-Huei Wu Chou, Wen-Shiang Wu, Kun-Ju Lin, Hsiu-Chen Chang, Tzu-Chen Yen, Rou-Shayn Chen, Shiaw-Pyng Wey, Chin-Song Lu, PINK1 mutation in Taiwanese early-onset parkinsonism, Journal of Neurology, 2007, 254, 10, 1347

    CrossRef

  79. 79
    Hélène Plun-Favreau, Kristina Klupsch, Nicoleta Moisoi, Sonia Gandhi, Svend Kjaer, David Frith, Kirsten Harvey, Emma Deas, Robert J. Harvey, Neil McDonald, Nicholas W. Wood, L. Miguel Martins, Julian Downward, The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1, Nature Cell Biology, 2007, 9, 11, 1243

    CrossRef

  80. 80
    Lee J. Martin, Transgenic Mice with Human Mutant Genes Causing Parkinson's Disease and Amyotrophic Lateral Sclerosis Provide Common Insight into Mechanisms of Motor Neuron Selective Vulnerability to Degeneration, Reviews in the Neurosciences, 2007, 18, 2

    CrossRef

  81. You have free access to this content81
    Thomas Gasser, Update on the genetics of Parkinson's disease, Movement Disorders, 2007, 22, S17
  82. 82
    Yoshikuni Mizuno, Nobutaka Hattori, Hideki Mochizuki, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  83. 83
    Anthony H.V. Schapira, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  84. 84
    Feng Wang, Xiuli Feng, Jinhong Ma, Haiqiang Zou, Piu Chan, A common A340T variant in PINK1 gene associated with late-onset Parkinson's disease in Chinese, Neuroscience Letters, 2006, 410, 2, 121

    CrossRef

  85. 85
    Miratul M. K. Muqit, Patrick M. Abou-Sleiman, Adrian T. Saurin, Kirsten Harvey, Sonia Gandhi, Emma Deas, Simon Eaton, Martin D. Payne Smith, Kerrie Venner, Antoni Matilla, Daniel G. Healy, William P. Gilks, Andrew J. Lees, Janice Holton, Tamas Revesz, Peter J. Parker, Robert J. Harvey, Nicholas W. Wood, David S. Latchman, Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress, Journal of Neurochemistry, 2006, 98, 1
  86. 86
    D. Wang, L. Qian, H. Xiong, J. Liu, W. S. Neckameyer, S. Oldham, K. Xia, J. Wang, R. Bodmer, Z. Zhang, Antioxidants protect PINK1-dependent dopaminergic neurons in Drosophila, Proceedings of the National Academy of Sciences, 2006, 103, 36, 13520

    CrossRef

  87. 87
    Jean-Marc Taymans, Chris Van den Haute, Veerle Baekelandt, Distribution of PINK1 and LRRK2 in rat and mouse brain, Journal of Neurochemistry, 2006, 98, 3
  88. 88
    Matthew James Farrer, Genetics of Parkinson disease: paradigm shifts and future prospects, Nature Reviews Genetics, 2006, 7, 4, 306

    CrossRef

  89. 89
    Cindy Zadikoff, Ekaterina Rogaeva, Ana Djarmati, Christine Sato, Shabnam Salehi-Rad, Peter St. George-Hyslop, Christine Klein, Anthony E. Lang, Homozygous and heterozygous PINK1 mutations: Considerations for diagnosis and care of Parkinson's disease patients, Movement Disorders, 2006, 21, 6
  90. 90
    M. I. Shadrina, P. A. Slominsky, Molecular genetics of Parkinson’s disease, Russian Journal of Genetics, 2006, 42, 8, 858

    CrossRef

  91. 91
    D. Gosal, O. A. Ross, M. Toft, Parkinson's disease: the genetics of a heterogeneous disorder, European Journal of Neurology, 2006, 13, 6
  92. 92
    Chiara Criscuolo, Giampiero Volpe, Anna De Rosa, Andrea Varrone, Roberta Marongiu, Pietro Mancini, Elena Salvatore, Bruno Dallapiccola, Alessandro Filla, Enza Maria Valente, Giuseppe De Michele, PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism, Movement Disorders, 2006, 21, 8
  93. 93
    Eng-King Tan, Kenneth Yew, Eva Chua, K. Puvan, Hui Shen, Esther Lee, Kim-Yoong Puong, Yi Zhao, Ratnagopal Pavanni, Meng-Cheong Wong, Dominic Jamora, Deidre de Silva, Kyaw-Thu Moe, Fung-Peng Woon, Yih Yuen, Louis Tan, PINK1 mutations in sporadic early-onset Parkinson's disease, Movement Disorders, 2006, 21, 6
  94. 94
    Shin-Ichiro Kubo, Nobutaka Hattori, Yoshikuni Mizuno, Recessive Parkinson's disease, Movement Disorders, 2006, 21, 7
  95. 95
    A. Wood-Kaczmar, S. Gandhi, N.W. Wood, Understanding the molecular causes of Parkinson's disease, Trends in Molecular Medicine, 2006, 12, 11, 521

    CrossRef

  96. 96
    EK Tan, K Yew, E Chua, H Shen, RD Jamora, E Lee, KY Puong, Y Zhao, R Pavanni, MC Wong, K Puvan, Y Yih, LCS Tan, Analysis of PINK1 in Asian patients with familial parkinsonism, Clinical Genetics, 2005, 68, 5
  97. 97
    Alistair J. Lewthwaite, David J. Nicholl, Genetics of Parkinsonism, Current Neurology and Neuroscience Reports, 2005, 5, 5, 397

    CrossRef

  98. 98
    Thomas Gasser, Genetics of Parkinsonʼs disease, Current Opinion in Neurology, 2005, 18, 4, 363

    CrossRef

  99. 99
    Luba M. Pardo, Cornelia M. van Duijn, In search of genes involved in neurodegenerative disorders, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2005, 592, 1-2, 89

    CrossRef

  100. 100
    Darren J. Moore, Andrew B. West, Valina L. Dawson, Ted M. Dawson, MOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE, Annual Review of Neuroscience, 2005, 28, 1, 57

    CrossRef

  101. 101
    A. Beilina, M. Van Der Brug, R. Ahmad, S. Kesavapany, D. W. Miller, G. A. Petsko, M. R. Cookson, Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability, Proceedings of the National Academy of Sciences, 2005, 102, 16, 5703

    CrossRef

  102. 102
    Christine Klein, Ana Djarmati, Katja Hedrich, Nora Schäfer, Cesa Scaglione, Roberta Marchese, Norman Kock, Birgitt Schüle, Anja Hiller, Thora Lohnau, Susen Winkler, Karin Wiegers, Robert Hering, Peter Bauer, Olaf Riess, Giovanni Abbruzzese, Paolo Martinelli, Peter P Pramstaller, PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism, European Journal of Human Genetics, 2005, 13, 9, 1086

    CrossRef

  103. 103
    S. Gandhi, P. M. Abou-Sleiman, D. G. Healy, M. Weale, W. Gilks, K. Ahmadi, D. B. Goldstein, N. W. Wood, Population genetic approaches to neurological disease: Parkinson's disease as an example, Philosophical Transactions of the Royal Society B: Biological Sciences, 2005, 360, 1460, 1573

    CrossRef

  104. 104
    Margery Mark, Psychiatric Issues in Parkinson's Disease, 2005,

    CrossRef

  105. 105
    John Hardy, J. William Langston, How many pathways are there to nigral death?, Annals of Neurology, 2004, 56, 3
  106. 106
    Daniel G Healy, Patrick M Abou-Sleiman, Nicholas W Wood, PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism, The Lancet Neurology, 2004, 3, 11, 652

    CrossRef

  107. 107
    Enza Maria Valente, Sergio Salvi, Tamara Ialongo, Roberta Marongiu, Antonio Emanuele Elia, Viviana Caputo, Luigi Romito, Alberto Albanese, Bruno Dallapiccola, Anna Rita Bentivoglio, PINK1 mutations are associated with sporadic early-onset parkinsonism, Annals of Neurology, 2004, 56, 3